Filing Details
- Accession Number:
- 0001209191-16-130106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-29 17:26:35
- Reporting Period:
- 2016-06-27
- Filing Date:
- 2016-06-29
- Accepted Time:
- 2016-06-29 17:26:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178711 | Paratek Pharmaceuticals Inc. | PRTK | Pharmaceutical Preparations (2834) | 330960223 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403748 | Omega Fund Iii, L.p. | 1 Royal Plaza, Royal Avenue St. Peter Port Guernsey, Channel Islands X0 GY1 2HL | No | No | Yes | No | |
1528382 | Omega Fund Iv, L.p. | 1 Royal Plaza, Royal Avenue St. Peter Port Guernsey, Channel Islands X0 uk | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-06-27 | 76,923 | $13.00 | 1,187,365 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2016-06-27 | 384,615 | $13.00 | 779,802 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The Reporting Persons are part of a "group" as defined in Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended (which group also includes K/S Danish BioVenture ("Danish BV") and Danish BioVenture General Partner ApS, whose securities are beneficially owned by Clessidra, LLC. This group beneficially owns, in the aggregate, 2,600,410 shares of common stock of the issuer and warrants to purchase an additional6,412 shares of common stock of the issuer.
- The reported securities are held in the name of Omega Fund III, L.P. ("Omega III"). The Reporting Person disclaims beneficial ownership of these securities,except to the extent of its pecuniary interest therein.
- The reported securities are held in the name of Omega Fund IV, L.P. ("Omega IV"). The Reporting Person disclaims beneficial ownership of these securities,except to the extent of its pecuniary interest therein.